How industry and the NHS can work together to bridge the diagnostic gap in COPD
Mind the gap
Related Posts
A rare opportunity – PharmaTimes
Importance of continuous collaboration with rare disease communities At Blueprint Medicines, we aim to make […]
Poor spatial navigation could predict Alzheimer’s before symptom onset
Around 900,000 people in the UK are affected by the progressive neurodegenerative disease Researchers from […]
Grifols pioneers high-tech analysis of plasma bank to detect Parkinson’s disease
Initiative aims to identify plasma-based biomarkers for early detection Grifols has received a grant from […]